Gastrointestinal Stents Market to Grow with a CAGR of 5.38% through 2031
Technological innovations and growing awareness are
expected to drive growth in the Global Gastrointestinal Stents Market over the
forecast period, 2027-2031.
According to TechSci Research report, “Gastrointestinal
Stents Market – Global Industry Size, Share, Trends, Competition Forecast
& Opportunities, 2031F”, the Global Gastrointestinal Stents Market will grow from USD 557.19 Million in 2025 to USD 771.78 Million by 2031 at a 5.58% CAGR. This can be attributed to an evolving
regulatory landscape. Regulatory bodies in various countries have facilitated market growth. By providing clear guidelines and standards for
the approval and use of gastrointestinal stents, regulators have increased confidence among healthcare providers and patients, thereby making these devices more readily available and widely adopted.
3D printing technology is revolutionising
medical device manufacturing, including the production of gastrointestinal
stents. This technology allows for the creation of patient-specific stents,
which can provide a more precise fit and improved efficacy. Customised stents
are expected to become increasingly prevalent in the market.
The market studied was significantly impacted by the COVID-19 pandemic, primarily due to restrictions placed on non-emergency procedures during this period. As reported in a July 2020 study by Matthew D. Rutter, endoscopy procedures declined substantially, with activity dropping to as low as 5% at one point and only gradually recovering to 20% by the study's conclusion. Likewise, in the early stages of the pandemic, New York's major hospital systems were overwhelmed with COVID-19 patients, resulting in a dramatic reduction in GI services, with procedural volumes plummeting by 80-90%. Consequently, the pandemic-induced reduction in gastrointestinal procedures dampened market growth. However, with the pandemic now under control, a rebound in market activity is anticipated in the near future.
Furthermore, the market's growth is bolstered by the increasing prevalence of gastrointestinal diseases and an aging population. For example, the Crohn's & Colitis Foundation estimated in 2020 that a significant proportion of individuals with Crohn's disease would require surgical interventions during their lifetime, indicating a crucial need for GI stents. The rising incidence of Crohn's disease underscores the potential for substantial market growth in this segment. The prevalence of celiac disease, as reported by the Celiac Disease Foundation in 2020, varied by region and demographic group. With celiac disease being more prevalent in specific populations, particularly among females and children, the growing incidence of gastrointestinal diseases like celiac disease is expected to drive robust market growth over the forecast period.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Gastrointestinal
Stents Market”
The Global Gastrointestinal Stents Market is segmented by product type, application, region, and company.
Based on application, Colorectal Cancer is projected to be the fastest-growing segment in the forecast period, driven by its rising global incidence and aging population. Advanced age remains the most significant risk factor, with developed countries despite accounting for a smaller share of the global population—reporting disproportionately high case numbers due to lifestyle and genetic predispositions. Notably, emerging markets like India are also witnessing an upward trend in colorectal cancer diagnoses. This growing disease burden, coupled with heightened awareness and improved diagnostic capabilities, is expected to propel strong growth in the colorectal cancer segment across global healthcare markets.
Major companies operating in the Global Gastrointestinal
Stents Market are:
- Boston Scientific Corporation
- Cook Group Inc.
- Becton Dickinson & Co Ltd
- CONMED Corporation
- Cantel Medical LLC
- ELLA-CS, s.r.o.
- Hobbs Medical Inc.
- Merit Medical Systems, Inc.
- Olympus Corp.
- Diagmed Healthcare Ltd.
Download
Free Sample Report
Customers may also request a 10% discount on this report.
“The global gastrointestinal stents market is on the
cusp of transformation, driven by innovative technologies, personalized
medicine, and a shift toward minimally invasive procedures. The emergence of
biodegradable stents, drug-eluting capabilities, 3D printing, and AI, coupled
with the expansion of telemedicine and global market reach, all point to a
dynamic and promising future for the gastrointestinal stents market. These
trends are set to enhance patient care, reduce complications, and improve the quality
of life for individuals with gastrointestinal disorders, marking an exciting
era in medical device development and healthcare delivery,” said Mr Karan
Chechi, Research Director of TechSci Research, a research-based management
consulting firm.
“Gastrointestinal Stents Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Biliary Stent, Colonic Stent, Duodenal Stent, Esophageal Stent, Pancreatic Stent), By Application (Biliary Disease, Colorectal Cancer, Stomach Cancer, Inflammatory Bowel Disease, Others), By Region & Competition, 2021-2031F”, has evaluated the future growth potential of Global
Gastrointestinal Stents Market and provides statistics & information on
market size, structure and future market growth. The report aims to provide cutting-edge market intelligence and help decision-makers make sound investment
decisions. The report also identifies and analyses emerging trends, as well as essential drivers, challenges, and opportunities, in the Global Gastrointestinal Stents Market.
Contact
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com